Clik here to view.
东芝推出搭载兼容NFC论坛类型3标签的有线接口的标签芯片
东京 (美国商业资讯)–东芝公司(Toshiba Corporation) (TOKYO:6502)今天宣布推出搭载嵌入式有线接口的“T6NE7”。T6NE7是一种兼容NFC[1]论坛类型3标签[2] (NFC Forum Type 3 Tag)的标签芯片(tag IC)，样品出货即日启动，而批量生产预计于2014年8月启动。...
View ArticleClik here to view.
Clik here to view.
NCDSER Purchases Instem’s Provantis Preclinical Software Suite
CONSHOHOCKEN, Pa. Instem, a leading provider of IT solutions to the global early development healthcare market, is pleased to announce that the National Shanghai Center for Drug Safety Evaluation...
View ArticleClik here to view.
PeptiDream Announces the Appointment of Dr. Keiichi Masuya as Chief Operating...
TOKYO PeptiDream Inc., a public Tokyo-based biopharmaceutical company (PeptiDream) (TOKYO:4587) announced today, the appointment of Dr. Keiichi Masuya as Chief Operating Officer (COO). Dr. Masuya...
View ArticleClik here to view.
GVK BIO Launches a New ‘Brand’ for a Renewed Customer Focus in the Clinical...
MUMBAI, India GVK Biosciences (GVK BIO), Asia’s leading Discovery Research and Development organization today unveiled a new brand CLINOGENT in the Clinical Development industry. CLINOGENT provides...
View ArticleClik here to view.
NCDSER购买Instem的Provantis临床前软件套件
宾夕法尼亚州肯肖霍肯 (美国商业资讯) — Instem是面向早期开发健康保健市场的IT解决方案的领先提供商，公司欣然宣布，国家上海新药安全评价研究中心(NCDSER)（又名上海益诺思生物技术有限公司）已购买Provantis®临床前软件套件，以便在该公司设在中国上海浦东张江高科技园区的研发设施中实现实验室流程的自动化。...
View ArticleClik here to view.
CEL-SCI Expands Its Phase III Head and Neck Cancer Trial into Sri Lanka
VIENNA, Va. CEL-SCI Corporation (NYSE MKT:CVM) today announced that Sri Lanka’s Ministry of Health has cleared the Company to commence patient enrollment for its Phase III Head and Neck Cancer...
View ArticleClik here to view.
Adoption Increases for VeriTeQ’s “Q Inside” Breast Implant Safety Technology
DELRAY BEACH, Fla. VeriTeQ Corporation (“VeriTeQ”) (OTC Markets: VTEQ), a provider of implantable medical device identification and radiation dose measurement technologies, announced today that the...
View ArticleClik here to view.
Terumo BCT Opens Manufacturing Facility in Vietnam
LAKEWOOD, Colo. Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies, today announced the opening of its new 91,440-square-meter facility near Ho Chi Minh...
View ArticleClik here to view.
Terumo BCT在越南的制造工厂开张
科罗拉多州LAKEWOOD (美国商业资讯) — 血液成分、治疗性血浆分离置换法和细胞技术的全球领先者Terumo BCT今天宣布，其在越南胡志明市附近开张了一家面积达91,440平方米的新工厂。该设施投资1亿美元，为Terumo BCT的全球业务扩张提供支持。当制造运营于2015年上半年开始时，这一新的制造工厂将提供增加的产能。 Terumo BCT在越南的新制造工厂。（照片：美国商业资讯）...
View ArticleClik here to view.
テルモBCTがベトナムの製造施設を開所
米コロラド州レイクウッド （ビジネスワイヤ） — 血液成分・治療用アフェレシス・細胞技術の世界的リーダーであるテルモBCTは本日、ベトナムのホーチミン市近郊における9万1440平方メートルの新施設の開所を発表しました。1億ドルの本製造施設はテルモBCTの事業拡大を世界規模で支えるものです。2015年前半に製造業務が開始されれば、この新しい製造施設は当社の製造能力を増強することになります。...
View ArticleClik here to view.
Starpharma: VivaGel® Condom Receives TGA Device Certification – Launch...
MELBOURNE, Australia Starpharma (ASX:SPL) (OTCQX:SPHRY) today announced achievement of a major milestone with the receipt of Conformity Assessment Certification for the VivaGel® condom by the...
View ArticleClik here to view.
Berry Genomics and Illumina Co-Develop Integrated Next-Generation Sequencing...
BEIJING & SAN DIEGO Berry Genomics Co. Ltd. announced today it has chosen Illumina Inc’s. (NASDAQ: ILMN) next-generation sequencing (NGS) technology as the platform on which Berry will secure...
View ArticleClik here to view.
Genocea HSV-2 Immunotherapeutic GEN-003 Elicits Significant, Durable T Cell...
CAMBRIDGE, Mass. Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, today presented data from a Phase 1/2a...
View ArticleClik here to view.
Iroko Pharmaceuticals凭借新的战略协议继续扩大ZORVOLEX®在拉丁美洲的商业化
费城 (美国商业资讯)–Iroko Pharmaceuticals, LLC是一家致力于推动镇痛科学的全球性专科制药公司，该公司今天宣布，其附属公司Iroko Pharmaceuticals Inc.已就在拉丁美洲特定国家推广和销售ZORVOLEX®（双氯芬酸）胶囊的独家权益与CALOX DE COSTA RICA...
View ArticleClik here to view.
イロコ・ファーマシューティカルズ、中南米での新たな戦略的提携によりZORVOLEX®の商業化をさらに推し進める
フィラデルフィア （ビジネスワイヤ）–鎮痛科学の前進に専心する世界的スペシャリティー製薬会社のイロコ・ファーマシューティカルズLLCは本日、系列会社のイロコ・ファーマシューティカルズ株式会社が、中南米の一定の国々でZORVOLEX®（ジクロフェナク）カプセルを上市・販売する独占的権利につき、CALOX DE COSTA RICA...
View ArticleClik here to view.
Seegene to Unveil at AACC 2014 the Innovative Real-Time PCR Technology That...
GAITHERSBURG, Md. & SEOUL, South Korea Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced “MuDT™” technology, the industry’s first real-time PCR...
View ArticleClik here to view.
ONCODESIGN: 1st Half of 2014
DIJON, France ONCODESIGN, a biotechnology company serving the pharmaceutical industry in the discovery of new therapeutic molecules to fight cancer and other serious illnesses with no known...
View ArticleClik here to view.
Biosceptre Announces Positive Phase I Results for BIL-010t to Treat Basal...
CAMBRIDGE, England Biosceptre, the oncology company developing antibody products that target the nf-P2X7 receptor, announces positive results from its Phase I trial to assess the safety and...
View ArticleClik here to view.
Dr. Reddy’s to Release Q1 FY15 Results on July 30, 2014
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting. The results will be...
View Article